글로벌 플라크 건선 시장 – 2029년까지의 산업 동향 및 예측

플라크 건선 시장 분석 및 통찰력

플라크 건선은 건선의 가장 기본적인 형태로, 전체 건선 사례의 80~90%를 차지합니다. 플라크 건선은 피부에 두껍고 붉은 반점이 특징인 자가면역 질환입니다. 이러한 플라크는 무릎, 두피, 팔꿈치에서 가장 흔히 발견됩니다. 그러나 신체의 다른 부위에도 나타날 수 있습니다. 가려움증, 통증, 출혈 가능성이 있습니다. 플라크 건선의 정확한 원인은 알려져 있지 않습니다.

플라크 건선은 지지적이고 증상의 심각성을 줄이는 것을 목표로 합니다. Data Bridge Market Research는 플라크 건선 시장이 2022년에서 2029년까지의 예측 기간 동안 6.50%의 CAGR로 성장할 것이라고 분석합니다. 2021년에 263억 7천만 달러였던 시장 가치는 2029년에 472억 4천만 달러에 도달할 것입니다. 더 나은 의료 인프라에 대한 수요가 증가함에 따라 플라크 건선 시장이 앞으로 나아가고 있습니다.

시장 정의

플라크 건선은 건선의 가장 기본적인 형태이며 전체 건선의 80%~90%를 차지합니다. 플라크 건선은 피부에 두껍고 붉은 반점이 나타나는 자가면역 질환입니다. 이러한 플라크는 일반적으로 무릎, 두피 및 팔꿈치에 나타납니다. 그러나 신체의 다른 부위에도 나타날 수 있습니다. 가려움증, 통증 및 출혈이 있을 수 있습니다. 플라크 건선의 정확한 원인은 아직 알려지지 않았습니다.

플라크 건선 시장 범위 및 세분화

Plaque psoriasis Market Dynamics

Drivers

• Rise in psoriasis prevalence

The rise in psoriasis prevalence and a rich promising pipeline of drugs are expected to drive growth in the plaque psoriasis market during the forecast period.

• Increasing investment for healthcare infrastructure

The change in lifestyle is expected to fuel the growth of the plaque psoriasis market. Furthermore, an increase in treatment awareness is expected to cushion the growth of the plaque psoriasis market

• High prevalence of alcohol and smoking consumption

Increased alcohol and smoking consumption, an unhealthy diet, and sedentary living will fuel the growth of the plaque psoriasis market in the coming years.

growth rate plaque psoriasis market in future.

Restraints/Challenges

The negative side effects of existing medications, on the other hand, are expected to stymie the growth of the plaque psoriasis market over the forecast period. Furthermore, however, because there is no disease-modifying treatment available for the conditions, and current treatment only provides symptomatic relief, the growth of the plaque psoriasis market may be hampered in the near future.

This plaque psoriasis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on plaque psoriasis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Plaque psoriasis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Plaque Psoriasis Market

The COVID-19 pandemic initially had a negative growth impact on the psoriasis market, owing to guidelines published by various regulatory bodies indicating that patients receiving psoriasis treatment are more likely to become infected with COVID-19. The International Psoriasis Council (IPC) recommended that physicians discontinue or postpone the prescription of immunosuppressant medications in March 2020. However, in September 2020, researchers from the University of Pennsylvania's Perelman School of Medicine and 16 other research institutions from the United States and Canada, in collaboration with the National Psoriasis Foundation, developed guidelines to care for psoriasis patients during the coronavirus pandemic. The researchers discovered no evidence that medical interventions for psoriasis and psoriatic arthritis should be discontinued or altered in order to reduce COVID-19 risks.

Recent Development

• POETYK PSO-1, the first pivotal Phase 3 trial evaluating deucravacitinib (BMS-986165), a novel, oral, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of patients with moderate to severe plaque psoriasis, yielded positive results in November 2020 for Bristol Myers Squibb.
• After receiving marketing authorization from the European Commission in May 2020 for indications including psoriatic arthritis and plaque psoriasis, Lupin Limited and Mylan launched the biosimilar etanercept Nepexto in Germany in August 2020.
• Fujifilm Kyowa Kirin Biologics received Japanese regulatory approval in July 2020 for the manufacturing and marketing of the first adalimumab biosimilar in the island country for the indications of psoriasis vulgaris, arthritic psoriasis, pustular psoriasis, ankylosing spondylitis, entero-disease, Behcet's Crohn's disease, and polyarticular-course juvenile

Global Plaque Psoriasis Market Scope

The plaque psoriasis market is segmented on the basis of treatment, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Topical therapy
• Phototherapy
• Systemic agents
• Biologic therapies
• Others

Route of Administration

• Oral
• Injectable

End Use

• Hospitals
• Homecare
• Speciality centres
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Pipeline Analysis

Taltz (Ixekizumab), Cosentyx (Secukinumab), Siliq (Brodalumab), Tremfya (Guselkumab), Ilumya (Tildrakizumab), and SKYRIZI are examples of major approved Interlunkin antibodies (Risankizumab).

Plaque Psoriasis Market Regional Analysis/Insights

The plaque psoriasis market is analysed and market size insights and trends are provided by country, type, treatment, diagnosis, indications, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the plaque psoriasis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the plaque psoriasis market due to the increased prevalence of the disease. Moreover, the plaque psoriasis market in the region will benefit from a robust drug pipeline during the forecast period. Because of the increase in research expenditure, Asia-Pacific is expected to see significant growth in the plaque psoriasis market. Furthermore, rising public awareness of the disease is expected to drive the growth of the plaque psoriasis market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Plaque Psoriasis Market Share Analysis

The plaque psoriasis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to plaque psoriasis market.

Some of the major players operating in the plaque psoriasis market are

• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France)
• 베링거 인겔하임 인터내셔널 GmbH. (독일)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• Bayer AG(독일)
• 머크앤코(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 브리스톨-마이어스 스퀴브 회사(미국)
• 카딜라 파마슈티컬스(인도)
• 엘리 릴리 앤드 컴퍼니(미국)
• LEO Pharma A/S(덴마크)
• 시플라 주식회사(미국)
• Aurobindo Pharma(인도)
• 루팡(인도)
• 스미토모 주식회사(일본)

SKU-46052